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Dear Editor,  
Methicillin-resistant Staphylococcus aureus (MRSA) is widespread in intensive care units (ICUs) 
[1]. Several molecular components are important for the definition and genotyping of MRSA, such 
as Staphylococcal chromosome cassette mec (SCCmec) type, Panton-Valentine Leukocidin toxin 
(PVL) or staphylococcal protein A (spa) production. The genotypic characteristics of hospital 
acquired (HA-MRSA) strains are consistent with SCCmec type I, II, III, without PVL production 
whilst community acquired (CA-MRSA) strains often produce PVL with type IV or V SCCmec.   
We report here the molecular characteristics of ICU MRSA strains between 2011 and 2013 isolated 
from blood cultures or respiratory samples. Sensitivity to vancomycin, daptomycin and linezolid 
was tested with E-test and results were interpreted according to EUCAST breakpoints [2]. All 
samples were studied by SCCmec typing, PVL typing and spa-typing.  
There were 62 MRSA strains from respiratory samples (57, 92%) or blood (5, 8%): 54 (87%) HA-
MRSA and 9 (13%) CA-MRSA. There were 50 (93%) and 7 (87.5%) respiratory samples amongst 
HA-MRSA and CA-MRSA strains, respectively. The molecular characterization and spa typing 
analysis are reported in Table 1: most MRSA had SCCmec II (35 cases, 56.4%), of which 31 were 
HA-MRSA. The most common clone was t242 (50%) and it was associated with SCCmec type II 
(87%) and HA-MRSA (89%). All isolates were susceptible to linezolid, whilst 13 and 6 isolates had 
a MIC for vancomycin or daptomycin, respectively, above the EUCAST breakpoints for sensitivity. 
Ten of the t242 strains (32%) had a vancomycin MIC>2 mg/L, including one with a daptomycin 
MIC >1 mg/L. The t242 strain represented 77% (10 out of 13) of MRSA non-sensitive to 
vancomycin. These strains were further analyzed in order to confirm the high MIC value for 
vancomycin in a referral microbiology laboratory (MMARL - 
http://www.labmicrobiologia.unict.it/). 
This is the first epidemiological report with t242 as the predominant strain (50%) in Italy, with a 
higher frequency amongst HA-MRSA cases and associated with lower susceptibility to 
vancomycin. A European study in 2005-2006 of MRSA epidemiology from 19 laboratories showed 
that the prevalent spa-types in Italy were t041 (35.8%) and t008 (28.4%) [3].  
All the MRSA isolates were sensitive to linezolid, the most effective drug in treating ventilator-
associated pneumonia by MRSA. The characterization of MRSA strains with high MICs for 
vancomycin is important in remembering that vancomycin should be limited to selected cases, 
perhaps with low MICs, thereby questioning the empiric use in special settings. All the isolates 
were sensitive to daptomycin, confirming the microbiological activity against MRSA isolated from 
blood [4-5], even if it has no role in pneumonia.  
This is the first Italian report where t242 strains are predominant in the ICU setting, are mainly 
hospital-acquired and associated with SCCmec II genes. These strains are characterized by an 
increased MIC for vancomycin, whilst susceptibility to linezolid and daptomycin is preserved. 
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 Table 1. Molecular characterization of MRSA strains and Genetic clusters identified by  spa typing  
 
SCCmec N Esotoxin PVL 
I 11 
(17.7%) 
NEG 
II 35 
(56.4%) 
NEG 
III 0 NEG 
IV 16 
(25.8%) 
NEG 
Spa typing N  
t242 31 
(50 %) 
t001 7 
(11.3%) 
t008 8 
(12.9%) 
t514 4 
(6.4%) 
t223 
 
 
2 
(3.2%) 
Others 
(one each): 
t025, t041, t622, t2688, t2731, 
t3178, t5713, t6731, t8334, 
t9553 
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